DGX Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Šios dienos apimtis	579 272
Vidutinė apimtis	1.05M
Rinkos kapitalizacija	14.92B
EPS	$0 ( 2024-04-25 )
Kita pelno data	( $2.32 ) 2024-07-24
Last Dividend	$0.750 ( 2024-04-05 )
Next Dividend	$0 ( N/A )
P/E	18.09
ATR14	$0.0790 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-22	Gregg Vicky B	Buy	81	Common Stock
2024-04-22	Kuppusamy Karthik	Buy	45	Common Stock
2024-04-22	Plewman Patrick	Buy	69	Common Stock
2024-04-22	Samad Sam	Buy	24	Common Stock
2024-04-01	Ring Timothy M	Buy	311	Phantom Stock Units

INSIDER POWER
70.91
Last 98 transactions
Buy: 293 398 \| Sell: 50 988

Tūris Koreliacija

Ilgas: -0.35 (neutral)

Trumpas: -0.80 (moderate negative)

Signal:(42.582) Neutral

Quest Diagnostics Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
LLY	0.865
PCK	0.863
PFE	0.858
JNJ	0.856
MOH	0.848
CHAD	0.846
XLV	0.841
CLII	0.839
ADM	0.837
EVTL	0.835

10 Labiausiai neigiamai susiję koreliacijos
YSAC	-0.949
MTW	-0.895
MNSO	-0.887
BH	-0.878
STLA	-0.877
STN	-0.874
RDW	-0.871
NOA	-0.867
NGL-PC	-0.862
NGL-PB	-0.859

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Quest Diagnostics Inc Koreliacija - Valiuta/Žaliavos

0.07
( neutral )

0.00
( neutral )

-0.59
( weak negative )

0.01
( neutral )

0.23
( neutral )

Quest Diagnostics Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$9.25B
Bruto pelnas:	$2.96B (32.00 %)
EPS:	$7.59

FY	2023
Pajamos:	$9.25B
Bruto pelnas:	$2.96B (32.00 %)
EPS:	$7.59

FY	2022
Pajamos:	$9.88B
Bruto pelnas:	$3.43B (34.74 %)
EPS:	$8.12

FY	2021
Pajamos:	$10.79B
Bruto pelnas:	$4.21B (39.02 %)
EPS:	$16.91

Financial Reports:

No articles found.

Quest Diagnostics Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.660 (N/A)	$0.660 (N/A)	$0.660 (N/A)	$0.710 (N/A)	$0.710 (N/A)	$0.710 (N/A)	$0.710 (N/A)	$0.750 (N/A)	$0 (N/A)	$0 (N/A)

Quest Diagnostics Inc Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.66 - Increase likely (53.16%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0750	2004-01-06
Last Dividend	$0.750	2024-04-05
Next Dividend	$0	N/A
Payout Date	2024-04-22
Next Payout Date	N/A
# dividends	82	--
Total Paid Out	$26.61	--
Avg. Dividend % Per Year	1.55%	--
Score	5.89	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.66
Div. Directional Score	9.84	--

Next Divdend (Est)
(2024-07-10)

$0.762 Estimate 73.83 %

Dividend Stability

0.98 Excellent

Dividend Score

5.89

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2004	$0.300	0.83%
2005	$0.345	0.73%
2006	$0.390	0.76%
2007	$0.400	0.78%
2008	$0.400	0.77%
2009	$0.400	0.76%
2010	$0.400	0.65%
2011	$0.400	0.73%
2012	$0.680	1.18%
2013	$1.200	2.05%
2014	$1.290	2.44%
2015	$1.470	2.13%
2016	$1.580	2.23%
2017	$1.800	1.95%
2018	$1.950	1.97%
2019	$2.12	2.58%
2020	$2.21	2.09%
2021	$2.42	2.00%
2022	$2.60	1.58%
2023	$2.79	1.79%
2024	$1.460	1.04%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0911	1.500	8.18	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0606	1.200	7.98	9.57	[0 - 0.3]
returnOnEquityTTM	0.133	1.500	9.63	10.00	[0.1 - 1]
payoutRatioTTM	0.377	-1.000	6.23	-6.23	[0 - 1]
currentRatioTTM	0.970	0.800	-0.152	-0.122	[1 - 3]
quickRatioTTM	0.782	0.800	-0.109	-0.0868	[0.8 - 2.5]
cashRatioTTM	0.206	1.500	9.97	10.00	[0.2 - 2]
debtRatioTTM	0.349	-1.500	4.19	-6.29	[0 - 0.6]
interestCoverageTTM	7.95	1.000	8.17	8.17	[3 - 30]
operatingCashFlowPerShareTTM	12.00	2.00	6.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	8.53	2.00	5.73	10.00	[0 - 20]
debtEquityRatioTTM	0.756	-1.500	6.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.327	1.000	7.88	7.88	[0.2 - 0.8]
operatingProfitMarginTTM	0.142	1.000	9.16	9.16	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.274	1.000	9.59	9.59	[0.2 - 2]
assetTurnoverTTM	0.666	0.800	8.90	7.12	[0.5 - 2]
Total Score				12.03

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	17.62	1.000	8.32	0	[1 - 100]
returnOnEquityTTM	0.133	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	8.53	2.00	7.16	10.00	[0 - 30]
dividendYielPercentageTTM	2.15	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	12.00	2.00	6.00	10.00	[0 - 30]
payoutRatioTTM	0.377	1.500	6.23	-6.23	[0 - 1]
pegRatioTTM	0.619	1.500	9.21	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.143	1.000	8.91	0	[0.1 - 0.5]
Total Score				7.66

Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.